Findings

What do systematic reviews say?

69 questions · 74 findings · 9 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4 · 5.4%GRADE not reported 26 · 35.1%Very low 8 · 10.8%Low 15 · 20.3%Moderate 20 · 27%High 1 · 1.4%

GnRH agonists vs HCG

Miscarriage · subfertile women

GnRH agonist probably leads to higher miscarriage compared with HCG (moderate certainty).

1 finding from 1 review

Gonadotropin‐releasing hormone agonist versus HCG for oocyte triggering in antagonist‐assisted reproductive technology 2014 · Cochrane Headline outcomes only
OR 1.74 [1.1, 2.75]
11 studies · 1198 participants
Moderate

Summary of findings table ‐ Progestogens vs GnRH antagonists

Premature LH surge ‐ Own oocytes ‐ PCOS (high‐responders) ‐ Early phase stimulation protocol ‐ Frozen embryo transfer · assisted reproduction technology cycles

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
GRADE not reported

Summary of findings table ‐ Progestogens vs GnRH antagonists

MII oocytes · assisted reproduction technology cycles

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Summary of findings table ‐ Progestogens vs GnRH antagonists

Total dose of gonadotropins · assisted reproduction technology cycles

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 952 participants
Moderate

Summary of findings table ‐ Progestogens vs GnRH antagonists

Moderate or severe OHSS · assisted reproduction technology cycles

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 3 participants
High

Summary of findings table ‐ Progestogens vs GnRH antagonists

Oocyte pick‐up cancellation sensitivity analysis ‐ total · assisted reproduction technology cycles

Summary of findings table ‐ Progestogens showed no clear difference in oocyte pick‐up cancellation sensitivity analysis ‐ total compared with gnRH antagonists; GRADE not reported.

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
OR 0.86 [0.4, 1.83]
4 studies · 768 participants
GRADE not reported

Summary of findings table ‐ Progestogens vs GnRH antagonists

Miscarriage · assisted reproduction technology cycles

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 2 participants
Very low

Summary of findings table ‐ Progestogens vs GnRH antagonists

Cumulative pregnancy rate · assisted reproduction technology cycles

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
GRADE not reported

Summary of findings table ‐ Progestogens vs GnRH antagonists

Premature LH surge ‐ Donor oocytes ‐ Normoresponders ‐ Early phase stimulation protocol ‐ Fresh embryo transfer · assisted reproduction technology cycles

1 finding from 1 review

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation… 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
GRADE not reported